Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NTII - Miscellaneous -- Ignore unavailable to you. Want to Upgrade?

To: lazarre who wrote (1140)	2/7/2005 6:33:35 PM
From: John McCarthy	Respond to of 1296

Hi Zazarre - Sorry I did not get back to you sooner ..... (a) I own around 35,000 shares. (b) Everyone is free to speculate about NTI's need to do another placement. my speculation is that they are $15 million short and therefore will have to do one. I don't want to spend energy defending this feeling but I threw these numbers out on Yahoo some weeks ago .... they are a road map and probably better estimates could be made .... NOTE: I would NOT recommend NTII to anyone ... too many loose ends ... Yahoo post ========== Cash (all accounts) (a) Beginning Balance 9/30/04 ********** ON HAND ******** $16,581 Plus ******** INFLOWS ******** (b) Estimated Inflows for 5 Quarters Royalties: (1) This quarter $765 (2) Jan-Mar-05 $1,000 (3) Apl-Jun-05 $1,100 (4) Jul-Sep-05 $1,200 (5) Oct-Dec-05 $1,300 ------------------------ Total $5,365 ----------------------- equals ******** (c)Total Available Cash ******** $21,946 (a) + (b) less ******** OUTFLOWS ******** (d)Estimated OutFlows for 5 Quarters (1) This quarter $2,000 (2) Jan-Mar-05 $2,500 (3) Apl-Jun-05 $2,700 (4) Jul-Sep-05 $3,000 (5) Oct-Dec-05 $3,300 ------------------------ Total $13,500 ----------------------- ******** NET CASH ********** (e) AT Sept 30 - 2005 --------------------- $8,446 (c) minus (d) ===================== ================= end Yahoo post ================= Error:(e) Should really say Dec 31, 2005 One of the weird things on the horizon maybe as follows: (1) Xerecept works - but (a) No way to finance a sales team to sell it, and, (b) sales effort reduced by limited product need i.e. used only in chronic because of the (anticipated huge) cost difference between Xerecept vs Dex_I_cant spell_the_rest current steriod in use. Finally, it goes without saying that I hope I am dead wrong about all the stuff above, and time will tell. Whether I stay here or not largely depends on the upcoming results of the DN P2 trial. regards, John